Toxoplasmosis Testing Market is estimated to reach at a high CAGR of 6.4% during the forecast period (2022-2029)
2021-08-10
Ans) The global toxoplasmosis testing market valued US$ 354.3 million in 2019 and is estimated to reach US$ 576.7 million by 2027, growing at a CAGR of 6.4% during the forecast period (2022-2029).
Ans) The base year considered in the report is 2019.
Download Free Sample:https://www.datamintelligence.com/download-sample/toxoplasmosis-testing-market
Ans) The serological test market for toxoplasmosis testing is likely to reach USD 426.9 million in 2027, from its recorded valued of USD 260.0 million in 2019, growing at a CAGR of 6.5% during the forecast period.
Ans)North America occupied the highest market share of about 34.65% in 2019 which is expected to increase to 35.55% by 2027
Ans) North America is growing at the CAGR of 6.7% during the forecast period (2020-2027).
Ans) Some of the key players which are contributing to the growth of the market include ACON Biotech, Biokit, Biomérieux, Abbott Laboratories, Bio-Rad, Diasorin S.p.A., Bionote, Atlas Medical, LifeSpan BioSciences, Elitechgroup, Genemedi Suzhou Biotechnology, Gold Standard Diagnostic, Thermo Fisher Scientific., among others.
Get In Detailed of Toxoplasmosis Testing Market https://www.datamintelligence.com/research-report/toxoplasmosis-testing-market
About Us:
DataM Intelligence was incorporated in the early weeks of 2017 as a Market Research and Consulting firm with just two people on board. Within a span of less than a year, we have secured more than 100 unique customers from established organizations all over the world.
For more information:
Sai Kiran
Sales Manager at DataM Intelligence
Email: [email protected]
Tel: +1 877 441 4866
Website: www.datamintelligence.com
Sai Kiran
Sales Manager at DataM Intelligence
Email: [email protected]
Tel: +1 877 441 4866
We have 5000+ marketing reports and serve across 130+ countries